Venturi Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Venturi Wealth Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-40,000	Closed	-$127K	–	272
2018 Q3	$127K	Hold	40,000	–	–	0.02%	164
2018 Q2	$142K	Buy	+40,000	New	+$195K	0.03%	168
2018 Q1	–	Sell	-40,000	Closed	-$186K	–	202
2017 Q4	$186K	Hold	40,000	–	–	0.04%	189
2017 Q3	$292K	Hold	40,000	–	–	0.06%	163
2017 Q2	$289K	Hold	40,000	–	–	0.07%	154
2017 Q1	$232K	Buy	+40,000	New	+$219K	0.05%	160

Venturi Wealth Management's KERX Position: Q4 2018 in Review

Venturi Wealth Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 40,000 shares — an estimated $127K sold.

Venturi Wealth Management first reported a position in KERX in Q1 2017 and held it in 6 quarters. The position peaked at $292K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Venturi Wealth Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Venturi Wealth Management sold 40,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $127K.
Venturi Wealth Management first reported a position in Keryx Biopharmaceuticals Inc in Q1 2017 and held it in 6 quarters.
Venturi Wealth Management's Keryx Biopharmaceuticals Inc position peaked at $292K in Q3 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Venturi Wealth Management's 13F filing for Q4 2018, filed 12 Feb 2019.